2026-01-16 - Analysis Report
**Company Overview**
Unknown Company - GEV Stock Overview

**Return Rate Comparison**

* Cumulative return of review stock: **76.45%**
* Cumulative return of comparison stock (S&P 500, VOO): **32.90%**
* Divergence (max: 82.90, min: -0.80, current: 43.60, relative divergence: 53.00%)
* Rate of review stock: 76.45%
* Rate of comparison stock: 32.90%
* Divergence: **43.55%**

**Alpha, Beta Analysis**

* CAGR: **76.0%**
* MDD: **25.6%**
* Alpha: **44.0%**
* Beta: **N/A** (given 174.7B is an impossible Beta value, the actual Beta value was possibly given in a table that has no provided text)
* Capital (Billions USD): **N/A** ($174.7B provided as 'Cap(B)')

**Stock Price Fluctuations**

* Close: **$644.18**
* Last-market: **$642.09**
* Change: **-0.32%**
* 5-day SMA: **$637.39**
* 20-day SMA: **$656.24**
* 60-day SMA: **$614.77**

**RSI & PPO Index Indicators**

* Market Risk Indicator (MRI): **0.70** (0.9~1.0: High Investment Recommended, 0.7~0.9: Medium Investment, 0.4~0.7: Low Investment, <0.4: Very Risky)
* RSI: **44.38**
* PPO: **-0.83**
* Hybrid Signal: Buy (Cash 0%) Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: **-6.40** (-): worsening
* 7-day Rank change: **0** (0): flat
* 7-day Dynamic Expected Return change: **0.00** (0): flat
* Expected Return: **N/A** (given as 'nan%')

**Recent News & Significant Events**

* Several news articles were found but the content must only be printed in the analysis.

**Analyst Opinions**

* Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): **1.87** (~Buy)
- Opinions: **27**
- Target Price (avg/high/low): **$753.66**/**$1000.00**/**$500.00**

**Recent Earnings Analysis**

| Date    | EPS   | Revenue (B$) |
|---------|-------|---------------|
| 2025-11-10 | **-0.03** |  **0.04**   |
| 2025-08-11 | **0.01** |  **0.04**   |
| 2025-05-13 | **-0.09** |  **0.03**   |
| 2024-11-07 | **-0.09** |  **0.00**   |
| 2025-11-10 | **-0.09** |  **0.00**   |

* The quarterly earnings data shows significant fluctuations in profit margins, from 12.44% in 2024-09-30 to 19.04% in 2025-09-30, with significant drops in revenue from $10.56B in 2024-12-31 to $0 in 2025-11-10 and $0 in 2025-05-13.

**Financial Information**

### Revenue and Profitability

| Quarter | Revenue (B$) | Profit Margin (%) |
|---------|---------------|-------------------|
| 2025-09-30 |  **$9.97** |  **19.04%** |
| 2025-06-30 |  **$9.11** |  **20.26%** |
| 2025-03-31 |  **$8.03** |  **18.30%** |
| 2024-12-31 |  **$10.56** |  **20.11%** |
| 2024-09-30 |  **$8.91** |  **12.44%** |

### Capital and Profitability

| Quarter | Equity (B$) | ROE (%) |
|---------|--------------|---------|
| 2025-09-30 |  **$8.65**  |  **5.23%**  |
| 2025-06-30 |  **$8.88**  |  **5.79%**  |
| 2025-03-31 |  **$8.61**  |  **2.95%**  |
| 2024-12-31 |  **$9.55**  |  **5.07%**  |
| 2024-09-30 |  **$9.50**  |  **-1.01%**  |

**Comprehensive Analysis (Summary of previous items)**

The company has shown substantial growth in cumulative returns over the past period. The Alpha and Beta analysis indicates that the company has been significantly outperforming other assets and has shown significant growth potential. However, the recent price fluctuations and indicators suggest a more cautious approach, and a risk level of medium. 
With the recent earnings data, the fluctuations in revenue and profit margins suggest that the company is still developing. 
Given the current Market Risk Indicator (MRI) of 0.70 and the recent earnings data, we might need a more detailed analysis or additional data points to determine the overall potential of this investment opportunity.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.